99231-99-9

Upstream product

• 19309-39-8 1-methyl-4-(hydroxymethyl)-2,6,7-trioxabicyclo-[2.2.2]-octane 
• 100-44-7 benzyl chloride 
• 115-77-5 Pentaerythritol 
• 100-39-0 benzyl bromide 

Downstream Products

• 632293-73-3 3-[bis-(4-methoxy-phenyl)-phenyl-methoxy]-2,2-bis-[bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-propan-1-ol 
• 131626-89-6 C₄₂H₅₁N₃O₁₃ 
• 130147-56-7 2,2'-<<2-<<<(2-hydroxyphenyl)methylene>amino>-methyl>-2-<(phenylmethoxy)methyl>-1,3-propanediyl>bis(nitrilomethylidyne)>bisphenol 
• 130147-43-2 ((3-azido-2,2-bis(azidomethyl)propoxy)methyl)benzene 
• 130147-44-3 2-(aminomethyl)-2-((benzyloxy)methyl)propane-1,3-diamine 
• 939056-09-4 [3-(2,2,2-trifluoro-1,1-bis-trifluoromethyl-ethoxy)-2,2-bis-(2,2,2-trifluoro-1,1-bis-trifluoromethyl-ethoxymethyl)-propoxymethyl]-benzene 
• 130147-42-1 2-<(benzyloxy)methyl>-2-(hydroxymethyl)-1,3-propanediol 

Relevant academic research and scientific papers

RAPAMYCIN ANALOGS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

Development of Tetramethylenedisulfotetramine (TETS) Hapten Library: Synthesis, Electrophysiological Studies, and Immune Response in Rabbits.

There is a need for fast detection methods for the banned rodenticide tetramethylenedisulfotetramine (TETS), a highly potent blocker of the γ-aminobutyric acid (GABAA) receptors. General synthetic approach toward two groups of analogues was dev

A new having glucoskeleton threotol Pentaphenol alkylalkoxysilane compd. contg., using the same and its intermediate surface modifying agent

PROBLEM TO BE SOLVED: To provide a novel surface modifier having high solubility to various organic solvents and excellent water repellency and oil repellency without containing a long-chain perfluoroalkyl group which is a problem in terms of environment and to provide an intermediate thereof.SOLUTION: There are provided a compound intermediate represented by the following general formula (1): [HCFCFOCH]C[CHOH](1) (where m is 2 or 3 and n is an integer satisfying 4-m), a fluorine-containing alkoxysilane compound represented by the following general formula (2): [HCFCFOCH]C[CH-X-Y-Si(OR)](2) (where m and n are the same as in general formula (1); X is a linking group representing an intermolecular interaction; Y is an alkylene group having 1 to 12 carbon atoms; and Ris an alkyl group having 1 to 6 carbon atoms) which is derived from the intermediate; and a surface modifier containing the fluorine-containing alkoxysilane compound as a constituent component.

CONJUGATED ANTISENSE COMPOUNDS AND THEIR USE

Provided herein are oligomeric compounds with conjugate groups. In certain embodiments, the oligomeric compounds are conjugated to N-Acetylgalactosamine.

The design and synthesis of highly branched and spherically symmetric fluorinated oils and amphiles

A new surfactant design principle, based on concepts borrowed from protein science, is proposed. Using this principle, a class of highly branched and spherically symmetric fluorinated oils and amphiles has been designed and synthesized, for potential appl

HIGHLY FLUORINATED OILS AND SURFACTANTS AND METHODS OF MAKING AND USING SAME

Disclosed are compounds comprising the structure (I): In one aspect, the compounds exhibit maximum symmetric branching. Also disclosed are bilayers, micelles, coatings, and nanoparticles comprising the disclosed compounds. Also disclosed are processes for